$JVA
COFFEE HOLDING CO INC Stock $jva

$jva Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224005726 Filed on February 09, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$19.54M	$18.76M	$68.17M
YoY Change	6.63%	21.12%	3.75%
Cost Of Revenue	$16.06M	$15.40M	$57.21M
YoY Change	0.34%	10.93%	4.61%
Gross Profit	$3.480M	$3.358M	$10.96M
YoY Change	49.99%	109.35%	-0.5%
Gross Profit Margin	17.81%	17.9%	16.08%
Selling, General & Admin	$2.690M	$3.101M	$11.68M
YoY Change	-8.55%	-13.93%	-10.07%
% of Gross Profit	77.29%	92.35%	106.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$154.5K	$153.6K	$593.6K
YoY Change	10.19%	-5.73%	1.54%
% of Gross Profit	4.44%	4.57%	5.42%
Operating Expenses	$2.863M	$3.101M	$12.29M
YoY Change	-8.26%	-13.94%	-24.84%
Operating Profit	$616.9K	$257.0K	-$1.332M
YoY Change	-177.02%	-112.86%	-75.06%
Interest Expense	$117.5K	-$1.500K	$563.4K
YoY Change	-9.91%	-98.03%	150.33%
% of Operating Profit	19.05%	-0.58%
Other Income/Expense, Net	-$123.6K	$0.00	$227.9K
YoY Change	-221.52%		-188.08%
Pretax Income	$493.4K	$255.5K	-$1.104M
YoY Change	-170.55%	-105.27%	-80.28%
Income Tax	$142.3K	$87.28K	-$268.2K
% Of Pretax Income	28.85%	34.16%
Net Earnings	$351.0K	$168.3K	-$835.6K
YoY Change	-165.97%	-104.44%	-77.69%
Net Earnings / Revenue	1.8%	0.9%	-1.23%
Basic Earnings Per Share	$0.06		-$0.15
Diluted Earnings Per Share	$0.06	$0.03	-$0.15
COMMON SHARES
Basic Shares Outstanding	5.709M shares		5.709M shares
Diluted Shares Outstanding	5.709M shares		5.709M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.408M	$2.734M	$2.734M
YoY Change	-43.41%	8.67%	8.67%
Cash & Equivalents	$2.408M	$2.734M
Short-Term Investments
Other Short-Term Assets	$493.5K	$413.8K	$413.8K
YoY Change	53.99%	-4.25%	-4.25%
Inventory	$17.01M	$18.99M	$18.99M
Prepaid Expenses	$310.9K	$365.9K
Receivables	$8.070M	$7.983M	$7.983M
Other Receivables	$1.663M	$3.862M	$3.862M
Total Short-Term Assets	$29.65M	$33.98M	$33.98M
YoY Change	-0.31%	7.18%	7.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.348M	$3.494M	$6.191M
YoY Change	2.4%	9.21%	1.96%
Goodwill
YoY Change
Intangibles	$327.0K	$327.0K
YoY Change	0.0%	0.0%
Long-Term Investments	$33.65K	$39.68K	$39.68K
YoY Change	-90.37%	-88.81%	-98.61%
Other Assets	$1.390M	$1.471M	$1.471M
YoY Change	-14.32%	-3.39%	-3.39%
Total Long-Term Assets	$7.931M	$8.213M	$8.213M
YoY Change	-28.6%	-25.27%	-25.27%
TOTAL ASSETS
Total Short-Term Assets	$29.65M	$33.98M	$33.98M
Total Long-Term Assets	$7.931M	$8.213M	$8.213M
Total Assets	$37.58M	$42.19M	$42.19M
YoY Change	-8.0%	-1.17%	-1.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.446M	$5.206M	$3.681M
YoY Change	2.22%	36.48%	39.59%
Accrued Expenses	$563.5K	$255.6K	$1.781M
YoY Change	201.51%	15.81%	27.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due	$4.704M	$9.624M	$9.624M
YoY Change	111904.76%	229047.62%	229047.62%
Total Short-Term Liabilities	$10.75M	$15.38M	$15.38M
YoY Change	107.71%	138.82%	138.82%
LONG-TERM LIABILITIES
Long-Term Debt	$2.070K	$3.030K	$3.030K
YoY Change	-99.98%	-99.96%	-99.96%
Other Long-Term Liabilities	$2.765M	$3.095M	$3.095M
YoY Change	-16.7%	-8.41%	-8.41%
Total Long-Term Liabilities	$2.767M	$3.098M	$3.098M
YoY Change	-76.26%	-73.53%	-73.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.75M	$15.38M	$15.38M
Total Long-Term Liabilities	$2.767M	$3.098M	$3.098M
Total Liabilities	$13.51M	$18.48M	$18.23M
YoY Change	-19.71%	1.85%	1.87%
SHAREHOLDERS EQUITY
Retained Earnings	$9.843M	$9.492M
YoY Change	0.49%	-8.09%
Common Stock	$6.634K	$6.634K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.634M	$4.634M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$24.31M	$23.96M	$23.96M
YoY Change
Total Liabilities & Shareholders Equity	$37.58M	$42.19M	$42.19M
YoY Change	-8.0%	-1.17%	-1.17%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$351.0K	$168.3K	-$835.6K
YoY Change	-165.97%	-104.44%	-77.69%
Depreciation, Depletion And Amortization	$154.5K	$153.6K	$593.6K
YoY Change	10.19%	-5.73%	1.54%
Cash From Operating Activities	$4.595M	-$147.9K	$652.1K
YoY Change	63.9%	-94.35%	-111.99%
INVESTING ACTIVITIES
Capital Expenditures		$137.8K	$857.8K
YoY Change		-146.25%	-19.02%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$137.8K	-$857.8K
YoY Change		-146.25%	-19.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$4.921M	593.8K	$423.8K
YoY Change	470.39%	-82.56%	-92.03%
NET CHANGE
Cash From Operating Activities	$4.595M	-147.9K	$652.1K
Cash From Investing Activities		-137.8K	-$857.8K
Cash From Financing Activities	-$4.921M	593.8K	$423.8K
Net Change In Cash	-$326.1K	308.1K	$218.1K
YoY Change	-118.76%	-71.61%	-118.48%
FREE CASH FLOW
Cash From Operating Activities	$4.595M	-$147.9K	$652.1K
Capital Expenditures		$137.8K	$857.8K
Free Cash Flow	$4.595M	-$285.7K	-$205.7K
YoY Change	76.62%	-87.68%	-96.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001007019
CY2023Q4	us-gaap	Other Investments OtherInvestments		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts		usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity		usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
CY2023	JVA	Impairment Of Customer List And Noncompete Agreement ImpairmentOfCustomerListAndNoncompeteAgreement		usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2023	JVA	Payments To Capital Contributed By Noncontrolling Interest PaymentsToCapitalContributedByNoncontrollingInterest		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1		usd
CY2023	JVA	Distribution Of Inventory By Noncontrolling Interest DistributionOfInventoryByNoncontrollingInterest		usd
CY2023	us-gaap	Derivative Gain Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#CostOfRevenue
CY2022	us-gaap	Derivative Gain Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#CostOfRevenue
CY2023	us-gaap	Derivative Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#CostOfRevenue
CY2022	us-gaap	Derivative Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#CostOfRevenue
CY2022	us-gaap	Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense
CY2023	us-gaap	Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	JVA	Income Tax Reconciliation Foreign Income Tax Rate Permanent Items IncomeTaxReconciliationForeignIncomeTaxRatePermanentItems		usd
CY2023Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-10-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-32491
CY2023	dei	Entity Registrant Name EntityRegistrantName	COFFEE HOLDING CO., INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2238111
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3475 Victory Boulevard
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Staten Island
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10314
CY2023	dei	City Area Code CityAreaCode	(718)
CY2023	dei	Local Phone Number LocalPhoneNumber	832-0800
CY2023	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.001 Per Share
CY2023	dei	Trading Symbol TradingSymbol	JVA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	7972813	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5708599	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2733977	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2515873	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	144000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	144000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7983032	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7816473	usd
CY2023Q4	us-gaap	Receivable Investment Sale ReceivableInvestmentSale	3150000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	18986539	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	19252214	usd
CY2023Q4	us-gaap	Due From Correspondent Brokers DueFromCorrespondentBrokers	345760	usd
CY2022Q4	us-gaap	Due From Correspondent Brokers DueFromCorrespondentBrokers	818892	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	413752	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	432126	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	365876	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	866155	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	33978936	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	31701733	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3494450	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3199790	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	310383	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	279883	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	184750	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	215250	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68173404	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65706879	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	57214382	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	54692933	usd
CY2023Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	327000	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	327000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	39676	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	354444	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	2500000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2696159	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2871773	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1341407	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1073187	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	129523	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	449348	usd
CY2023Q4	us-gaap	Assets Assets	42191901	usd
CY2022Q4	us-gaap	Assets Assets	42692525	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5206442	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3814864	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9620000	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	876148	usd
CY2023Q4	us-gaap	Due To Correspondent Brokers DueToCorrespondentBrokers	292407	usd
CY2022Q4	us-gaap	Due To Correspondent Brokers DueToCorrespondentBrokers	1523563	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4200	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4200	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	255625	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	220734	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15378674	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6439509	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	8314000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2974579	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3136006	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	3034	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	9105	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	120523	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	243238	usd
CY2023Q4	us-gaap	Liabilities Liabilities	18476810	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18141858	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6633930	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6633930	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5708599	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5708599	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6634	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6634	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19094618	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19094618	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9491861	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10327437	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24795129	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-244462	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-244462	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23715091	usd
CY2023	us-gaap	Gross Profit GrossProfit	10959022	usd
CY2022	us-gaap	Gross Profit GrossProfit	11013946	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11680782	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12989032	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	2769552	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24550667	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42191901	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	925331	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	925331	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4633560	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4633560	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	23959553	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42692525	usd
CY2023	us-gaap	Officers Compensation OfficersCompensation	609935	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	594262	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	12290717	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	16352846	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1331695	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5338900	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	18947	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	14094	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-511878	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-47801	usd
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	650000	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	634181	usd
CY2023	us-gaap	Interest Expense InterestExpense	563351	usd
CY2022	us-gaap	Interest Expense InterestExpense	225043	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	227899	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-258750	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1103796	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5597650	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-268220	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-995793	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-835576	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4601857	usd
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-857072	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-835576	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3744785	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5708599	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5708599	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5708599	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5708599	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29370319	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	405821	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	554616	usd
CY2022	JVA	Minority Interest Inflow From Noncontrolling Interest Holders MinorityInterestInflowFromNoncontrollingInterestHolders	330000	usd
CY2022	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	399000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-857072	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3744785	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24550667	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24550667	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-835576	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23715091	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23715091	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-835576	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4601857	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	593600	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	584595	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2569785	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	415096	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	405821	usd
CY2023	us-gaap	Unrealized Gain Loss On Commodity Contracts UnrealizedGainLossOnCommodityContracts	758024	usd
CY2022	us-gaap	Unrealized Gain Loss On Commodity Contracts UnrealizedGainLossOnCommodityContracts	-721350	usd
CY2023	JVA	Loss From Equity Method Investments LossFromEquityMethodInvestments	314768	usd
CY2022	JVA	Loss From Equity Method Investments LossFromEquityMethodInvestments	47801	usd
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	650000	usd
CY2022	JVA	Impairment Of Customer List And Noncompete Agreement ImpairmentOfCustomerListAndNoncompeteAgreement	199767	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	718353	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	322030	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	674013	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-268220	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-995793	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	166559	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1068409	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-265675	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4563317	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-18374	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-110098	usd
CY2023	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-500279	usd
CY2022	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	790203	usd
CY2023	JVA	Increase Decrease In Deposits And Other Assets IncreaseDecreaseInDepositsAndOtherAssets	-197110	usd
CY2022	JVA	Increase Decrease In Deposits And Other Assets IncreaseDecreaseInDepositsAndOtherAssets	68757	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1391578	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1232776	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-272952	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-283444	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-416449	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	652083	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5437508	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	857760	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1059205	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-857760	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1059205	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3034783	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6427654	usd
CY2023	JVA	Proceeds From Cash Overdraft ProceedsFromCashOverdraft	-876148	usd
CY2022	JVA	Proceeds From Cash Overdraft ProceedsFromCashOverdraft	876148	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6071	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3987	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	399000	usd
CY2022	JVA	Payments To Capital Contributed By Noncontrolling Interest PaymentsToCapitalContributedByNoncontrollingInterest	-330000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1728783	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1914504	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	423781	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5316311	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	218104	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1180402	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2515873	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3696275	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2733977	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2515873	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	538363	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	202303	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1327039	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	146416	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	146416	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	3150000	usd
CY2022	JVA	Distribution Of Inventory By Noncontrolling Interest DistributionOfInventoryByNoncontrollingInterest	554616	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80E_eus-gaap--NatureOfOperations_zngGqgs2iNda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_82E_zAXrpya7y7bl">BUSINESS ACTIVITIES</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coffee Holding Co., Inc. (the “Company”) conducts wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. The Company’s core product, coffee, can be summarized and divided into three product categories (“product lines”) as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Wholesale Green Coffee:</i></b> unroasted raw beans imported from around the world and sold to large and small roasters and coffee shop operators;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private Label Coffee:</i></b> coffee roasted, blended, packaged and sold under the specifications and names of others, including supermarkets that want to have their own brand name on coffee to compete with national brands; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Branded Coffee:</i></b> coffee roasted and blended to the Company’s own specifications and packaged and sold under the Company’s eight proprietary and licensed brand names in different segments of the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s private label and branded coffee sales are primarily to customers that are located throughout the United States with limited sales in Canada and certain countries in Asia. Such customers include supermarkets, wholesalers, and individually-owned and multi-unit retailers. The Company’s unprocessed green coffee, which includes over 90 specialty coffee offerings, is sold primarily to specialty gourmet roasters and to coffee shop operators in the United States with limited sales in Australia, Canada, England and China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholesale green, private label, and branded coffee product categories generate revenues and cost of sales individually but incur selling, general and administrative expenses in the aggregate. There are no individual product managers and discrete financial information is not available for any of the product lines. The Company’s product portfolio is used in one business and it operates and competes in one business activity and economic environment. In addition, the three product lines share customers, manufacturing resources, sales channels, and marketing support. Thus, the Company considers the three product lines to be one single reporting segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company during the quarter ended April 30, 2022 had begun a restructuring process with its Generations subsidiary. As part of this restructuring approximately $<span id="xdx_902_eus-gaap--RestructuringCosts_pp0p0_c20220201__20220430_zoIt61zYPdd1" title="Restructuring costs">550,000</span> of its inventory was distributed to the non-controlling interest partner for $<span id="xdx_90C_eus-gaap--Cash_iI_pp0p0_c20220430_zF23SHqEKEJd" title="Cash">330,000</span> in cash. As part of the restructuring process, the Company recorded a write-down of obsolete inventory of $<span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20220201__20220430_zT9i9wGrMSt6" title="Write-down of obsolete inventory">718,353</span> and a write-off of accounts receivable of $<span id="xdx_90A_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_c20220201__20220430_zWO0b7DEtIG" title="Write-off of accounts receivable">415,096</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 29, 2022, Coffee Holding Co., Inc, a Nevada corporation (the “Company”), entered into a Merger and Share Exchange Agreement (the “Merger Agreement”), by and among the Company, Delta Corp Holdings Limited, a Cayman Islands exempted company (“Pubco”), Delta Corp Holdings Limited, a company incorporated in England and Wales (“Delta”), CHC Merger Sub Inc., a Nevada corporation and wholly owned subsidiary of Pubco (“Merger Sub”), and each of the holders of ordinary shares of Delta as named therein (the “Sellers”). Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company, with the Company surviving as a direct, wholly-owned subsidiary of Pubco (the “Merger”). As a result of the Merger, each issued and outstanding share of the Company common stock, $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220929__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zqJc1CuWJwZg" title="Common stock, par value">0.001</span> par value per share (the “JVA Common Stock”), will be cancelled and converted for the right of the holder thereof to receive one ordinary share, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220929__srt--TitleOfIndividualAxis__custom--PubcoMember_zrI5PHjZ1y7h" title="Common stock, par value">0.0001</span> of Pubco (the “Pubco Ordinary Shares”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Uncertainty Due to Geopolitical Events</b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although Russia’s invasion of Ukraine did not have a material adverse impact on the Company’s revenue or other financial results for the year ended October 31, 2022, at this time the Company is unable to fully assess the aggregate impact will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the economy, its impact to the businesses of the Company’s customers, and actions that may be taken by governmental authorities related to the war.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COFFEE HOLDING CO., INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OCTOBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - BUSINESS ACTIVITIES (cont’d):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COVID-19</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S. government in March 2020 and has negatively affected the U.S. and global economies, disrupted global supply chains, resulted in significant travel and transport restrictions, mandated closures and stay-at-home orders, and created significant disruption of the financial markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The continuing impact on the Company’s business including the decrease in our sales, the length and impact of stay-at-home orders and/or regional quarantines, labor shortages and employment trends, disruptions to supply chains, including its ability to obtain products from global suppliers, higher operating costs, the form and impact of economic stimulus and general overall economic instability, has contributed to and may continue to have a material adverse effect on the Company’s business, results of operations, financial condition and cash flows. At this time the full impact could not be fully determined.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going Concern</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended October 31, 2023, the Company incurred a net loss of $<span id="xdx_902_eus-gaap--NetIncomeLoss_iN_di_c20221101__20231031_zmfKvdUnkLga">835,576</span> generated cashflows from operations of $</span><span id="xdx_907_eus-gaap--NetCashProvidedByUsedInOperatingActivities_c20221101__20231031_z8SH9EuDweOg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">652,083</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, had net working capital of $<span id="xdx_90E_ecustom--WorkingCapitalDeficit_iI_pn5n6_c20231031_zo577qaUUQf3">18.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and equity of $<span id="xdx_909_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_pn5n6_c20231031_zbQdFvRfgTx7">23.7 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The Company’s line of credit of $ <span id="xdx_90C_eus-gaap--LinesOfCreditCurrent_iI_pn5n6_c20231031__us-gaap--LineOfCreditFacilityAxis__custom--JuneTwoThousandTwentyFourMember_zjqfESvswXZc">9.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, becomes due in June 2024, for which the Company will seek to obtain a renewal of the financing arrangement. There are certain financial covenants that the Company is in violation. The Company has not received a waiver from the lender. The lender has reserved its right to exercise its rights and remedies at any time in its sole discretion. The uncertainties surrounding the ability to receive a waiver and extending its line of credit when it becomes due raise substantial doubt as to whether existing cash and cash equivalents will be sufficient to meet its obligations as they become due within twelve months from the date the consolidated financial statements were issued. The current balance outstanding as of February 8, 2024 is approximately $<span id="xdx_909_eus-gaap--LinesOfCreditCurrent_iI_pn5n6_c20231031__us-gaap--LineOfCreditFacilityAxis__us-gaap--LineOfCreditMember_zlYtaopxZFM5">4.7 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The Company continues to expand its customer base, which is expected to increase margins and profitability in future periods. However, there can be no assurance of such continued success. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Restructuring Costs RestructuringCosts	550000	usd
CY2022Q2	us-gaap	Cash Cash	330000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	718353	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	415096	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-835576	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	652083	usd
CY2023Q4	JVA	Working Capital Deficit WorkingCapitalDeficit	18600000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23700000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zmlK1th6eSnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zMYOQd2Lh0Fc">USE OF ESTIMATES</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Significant estimates include, depreciable lives for long-lived assets, and valuation of goodwill and indefinitely lived intangible assets impairment testing. These estimates may be adjusted as more current information becomes available, and any adjustment could have a significant impact on recorded amounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2023Q4	JVA	Reserve For Other Allowances ReserveForOtherAllowances	35000	usd
CY2022Q4	JVA	Reserve For Other Allowances ReserveForOtherAllowances	35000	usd
CY2023Q4	JVA	Reserve For Sales Discount ReserveForSalesDiscount	44000	usd
CY2022Q4	JVA	Reserve For Sales Discount ReserveForSalesDiscount	44000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	144000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	144000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	1034966	usd
CY2022	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	2307714	usd
CY2023	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	1603746	usd
CY2022	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	1683401	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	758024	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-721350	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	189244	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-97037	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30500	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	62552	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2569785	usd
CY2021Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	408000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	81000	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	327000	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	327000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	-0	usd
CY2023Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	327000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	199767	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	35369	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	42001	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5708599	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5708599	shares
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68173404	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65706879	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68173404	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65706879	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zd5K10IBIOca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z6GwkCHICbv8">CONCENTRATION OF RISK</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions and brokerage firms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts at each institution are insured by the Federal Deposit Insurance Corporation (FDIC) up to certain limits. At October 31, 2023 and 2022, the Company had approximately $<span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20231031_zdqmrvBhItZ5" title="Cash excess of FDIC insured limits">2,092,000</span> and $<span id="xdx_90C_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20221031_zkPWdVXNiYF9" title="Cash excess of FDIC insured limits">625,000</span> in excess of FDIC insured limits, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounts at the brokerage firm contain cash and securities. Balances are insured up to $<span id="xdx_904_ecustom--CashSIPCInsuredAmount_iI_pp0p0_c20231031__srt--RangeAxis__srt--MaximumMember_zBpuKW6QhKJa" title="Cash, SIPC insured amount">500,000</span>, with a limit of $<span id="xdx_90F_ecustom--CashSIPCInsuredLimits_iI_c20231031_zdya6x33Son4" title="Cash SIPC insured limits">100,000</span> for cash, by the Securities Investor Protection Corporation (SIPC). At October 31, 2023 and 2022, the Company had approximately $<span id="xdx_907_ecustom--CashExcessOfSIPCInsuredLimits_iI_pp0p0_c20231031_z94gQjHwMxU" title="Cash excess of SIPC insured limits">373,000</span> and $<span id="xdx_90B_ecustom--CashExcessOfSIPCInsuredLimits_iI_pp0p0_c20221031_zPSzJRgHswO4" title="Cash excess of SIPC insured limits">1,560,000</span> in excess of SIPC insured limits, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COFFEE HOLDING CO., INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OCTOBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont’d): </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2092000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	625000	usd
CY2023Q4	JVA	Cash Sipc Insured Limits CashSIPCInsuredLimits	100000	usd
CY2023Q4	JVA	Cash Excess Of Sipc Insured Limits CashExcessOfSIPCInsuredLimits	373000	usd
CY2022Q4	JVA	Cash Excess Of Sipc Insured Limits CashExcessOfSIPCInsuredLimits	1560000	usd
CY2021Q3	us-gaap	Investments Investments	2500000	usd
CY2023Q4	us-gaap	Receivable Investment Sale ReceivableInvestmentSale	3150000	usd
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	650000	usd
CY2022Q4	JVA	Lease Payment Percent LeasePaymentPercent	0.0500	pure
CY2023Q4	JVA	Lease Payment Percent LeasePaymentPercent	0.0500	pure
CY2023Q4	us-gaap	Inventory Net InventoryNet	18986539	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	19252214	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	18986539	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	19252214	usd
CY2023Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	233766	usd
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	233766	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	900321	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	900321	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	8587858	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	7730098	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1184387	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1184387	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10906332	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10048572	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7411882	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6848782	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3494450	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3199790	usd
CY2023	us-gaap	Depreciation Depreciation	563100	usd
CY2022	us-gaap	Depreciation Depreciation	522043	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	3681123	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2637051	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1051685	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	784531	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	473634	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	393282	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5206442	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3814864	usd
CY2023Q4	JVA	Unused Line Of Credit UnusedLineOfCredit	2185219	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	9620000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	8314000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-223120	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-933489	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-45100	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-62304	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-268220	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-995793	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-268220	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-995793	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-231797	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1175507	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	265796	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-51500	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	135025	usd
CY2023	JVA	Income Tax Reconciliation Foreign Income Tax Rate Permanent Items IncomeTaxReconciliationForeignIncomeTaxRatePermanentItems	51500	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-36423	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-221107	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-268220	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-995793	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.18	pure
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	34539	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	34547	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	173058	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	28483	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	15643	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	28908	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	58355	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1039047	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	547570	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	602107	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	602237	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	105794	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	107298	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1838878	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1538708	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	70021	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	70021	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	427450	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	395500	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	497471	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	465521	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1341407	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1073187	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3641178	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2281518	usd
CY2023	us-gaap	General Discussion Of Pension And Other Postretirement Benefits GeneralDiscussionOfPensionAndOtherPostretirementBenefits	The Company has a 401(k) Retirement Plan, which covers all the full time employees who have completed one year of service and have reached their 21st birthday. The Company matches 100% of the aggregate salary reduction contribution up to the first 3% of compensation and 50% of aggregate contribution of the next 2% of compensation
CY2023	JVA	Aggregate Contribution Of Retirement Plan AggregateContributionOfRetirementPlan	80994	usd
CY2022	JVA	Aggregate Contribution Of Retirement Plan AggregateContributionOfRetirementPlan	75004	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2696159	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2871773	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	255625	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	220734	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2974579	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3136006	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3230204	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3356740	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	322030	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	674013	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	770429	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	393668	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	376683	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	367788	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	305648	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2027652	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4241868	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1011664	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3230204	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	429027	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	426271	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	210961	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	285696	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	120523	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	243238	usd
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0	usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1000000	shares
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	405821	usd

Files In Submission

Name	View Source	Status
0001493152-24-005726-index-headers.html	Edgar Link	pending
0001493152-24-005726-index.html	Edgar Link	pending
0001493152-24-005726.txt	Edgar Link	pending
0001493152-24-005726-xbrl.zip	Edgar Link	pending
ex-97.htm	Edgar Link	pending
ex10-27.htm	Edgar Link	pending
ex10-28.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
jva-20231031.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
jva-20231031_cal.xml	Edgar Link	unprocessable
jva-20231031_def.xml	Edgar Link	unprocessable
jva-20231031_lab.xml	Edgar Link	unprocessable
jva-20231031_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JVA
COFFEE HOLDING CO INC Stock $jva

2024 Q1 Form 10-K Financial Statement

#000149315224005726 Filed on February 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JVA COFFEE HOLDING CO INC Stock $jva

2024 Q1 Form 10-K Financial Statement

#000149315224005726 Filed on February 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JVA
COFFEE HOLDING CO INC Stock $jva